

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein K11-linked deubiquitination (GO:0035871) | 5.85415053 |
| 2 | regulation of memory T cell differentiation (GO:0043380) | 5.46545803 |
| 3 | regulation of establishment of cell polarity (GO:2000114) | 4.82175520 |
| 4 | behavioral response to nicotine (GO:0035095) | 4.56679204 |
| 5 | interferon-gamma production (GO:0032609) | 4.56403430 |
| 6 | regulation of appetite (GO:0032098) | 4.40096099 |
| 7 | negative regulation of multicellular organism growth (GO:0040015) | 4.40087784 |
| 8 | sex differentiation (GO:0007548) | 4.27470552 |
| 9 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.12725281 |
| 10 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 4.06068721 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.00889149 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 4.00889149 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.00889149 |
| 14 | regulation of action potential (GO:0098900) | 3.93236923 |
| 15 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.74736612 |
| 16 | reflex (GO:0060004) | 3.61884777 |
| 17 | piRNA metabolic process (GO:0034587) | 3.57069541 |
| 18 | synaptic transmission, cholinergic (GO:0007271) | 3.56476834 |
| 19 | regulation of sarcomere organization (GO:0060297) | 3.47375903 |
| 20 | serotonin receptor signaling pathway (GO:0007210) | 3.46651015 |
| 21 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.41358105 |
| 22 | NADH dehydrogenase complex assembly (GO:0010257) | 3.41358105 |
| 23 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.41358105 |
| 24 | sulfation (GO:0051923) | 3.39180319 |
| 25 | indolalkylamine metabolic process (GO:0006586) | 3.37113997 |
| 26 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.35186006 |
| 27 | neuronal action potential (GO:0019228) | 3.34480966 |
| 28 | activated T cell proliferation (GO:0050798) | 3.32388945 |
| 29 | chaperone-mediated protein transport (GO:0072321) | 3.30479412 |
| 30 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.29701706 |
| 31 | tryptophan metabolic process (GO:0006568) | 3.28716651 |
| 32 | killing of cells of other organism (GO:0031640) | 3.26486143 |
| 33 | disruption of cells of other organism (GO:0044364) | 3.26486143 |
| 34 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.13454193 |
| 35 | protein K63-linked deubiquitination (GO:0070536) | 3.13302453 |
| 36 | negative regulation of mast cell activation (GO:0033004) | 3.11266748 |
| 37 | positive regulation of vasculogenesis (GO:2001214) | 3.09171379 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 3.07415802 |
| 39 | detection of light stimulus involved in visual perception (GO:0050908) | 3.05099313 |
| 40 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.05099313 |
| 41 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.04122379 |
| 42 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.03815648 |
| 43 | primary amino compound metabolic process (GO:1901160) | 3.03744575 |
| 44 | protein complex biogenesis (GO:0070271) | 3.00991107 |
| 45 | translational termination (GO:0006415) | 2.98710493 |
| 46 | glycerophospholipid catabolic process (GO:0046475) | 2.95468631 |
| 47 | amine catabolic process (GO:0009310) | 2.93604881 |
| 48 | cellular biogenic amine catabolic process (GO:0042402) | 2.93604881 |
| 49 | neuronal action potential propagation (GO:0019227) | 2.93486953 |
| 50 | seminiferous tubule development (GO:0072520) | 2.93445371 |
| 51 | viral transcription (GO:0019083) | 2.93169278 |
| 52 | endoderm formation (GO:0001706) | 2.92802853 |
| 53 | kynurenine metabolic process (GO:0070189) | 2.90766014 |
| 54 | phospholipid translocation (GO:0045332) | 2.83572461 |
| 55 | lipid translocation (GO:0034204) | 2.83572461 |
| 56 | regulation of vasculogenesis (GO:2001212) | 2.81823741 |
| 57 | cholesterol catabolic process (GO:0006707) | 2.81674554 |
| 58 | sterol catabolic process (GO:0016127) | 2.81674554 |
| 59 | centrosome duplication (GO:0051298) | 2.80044856 |
| 60 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.79844259 |
| 61 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.76419590 |
| 62 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.74188687 |
| 63 | indole-containing compound metabolic process (GO:0042430) | 2.73361866 |
| 64 | ketone body metabolic process (GO:1902224) | 2.71955556 |
| 65 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.71667726 |
| 66 | regulation of glucocorticoid secretion (GO:2000849) | 2.70950701 |
| 67 | lymphangiogenesis (GO:0001946) | 2.70894633 |
| 68 | detection of temperature stimulus (GO:0016048) | 2.68302274 |
| 69 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.67824234 |
| 70 | DNA methylation involved in gamete generation (GO:0043046) | 2.66705866 |
| 71 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.66650109 |
| 72 | adaptation of signaling pathway (GO:0023058) | 2.62487424 |
| 73 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.59455167 |
| 74 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.58955331 |
| 75 | positive regulation of hair cycle (GO:0042635) | 2.58084604 |
| 76 | positive regulation of hair follicle development (GO:0051798) | 2.58084604 |
| 77 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.57855400 |
| 78 | parturition (GO:0007567) | 2.56041641 |
| 79 | thyroid hormone metabolic process (GO:0042403) | 2.54951903 |
| 80 | membrane depolarization during action potential (GO:0086010) | 2.53076387 |
| 81 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.52629510 |
| 82 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.52596632 |
| 83 | cellular response to electrical stimulus (GO:0071257) | 2.51864257 |
| 84 | protein neddylation (GO:0045116) | 2.51675265 |
| 85 | NAD biosynthetic process (GO:0009435) | 2.50155137 |
| 86 | serotonin metabolic process (GO:0042428) | 2.49738130 |
| 87 | axon ensheathment in central nervous system (GO:0032291) | 2.49548375 |
| 88 | central nervous system myelination (GO:0022010) | 2.49548375 |
| 89 | neuromuscular process controlling posture (GO:0050884) | 2.48636794 |
| 90 | sex determination (GO:0007530) | 2.47929258 |
| 91 | regulation of sequestering of triglyceride (GO:0010889) | 2.46594173 |
| 92 | cysteine metabolic process (GO:0006534) | 2.45849138 |
| 93 | positive regulation of fatty acid transport (GO:2000193) | 2.44541018 |
| 94 | flavonoid metabolic process (GO:0009812) | 2.44535341 |
| 95 | somite rostral/caudal axis specification (GO:0032525) | 2.44297758 |
| 96 | defense response to fungus (GO:0050832) | 2.43381811 |
| 97 | action potential (GO:0001508) | 2.42990702 |
| 98 | protein localization to lysosome (GO:0061462) | 2.42448515 |
| 99 | protein localization to vacuole (GO:0072665) | 2.42448515 |
| 100 | aromatic amino acid family catabolic process (GO:0009074) | 2.40330694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.37396875 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.84657193 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.62171150 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.31536246 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.83131145 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.62229593 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.62035183 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.38614050 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.12045838 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05144471 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04106258 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 2.01450958 |
| 13 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.91308742 |
| 14 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90508390 |
| 15 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.84293144 |
| 16 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.80312666 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.78756140 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78622084 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77701445 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76552339 |
| 21 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74594697 |
| 22 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.73012587 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72724406 |
| 24 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69616566 |
| 25 | AR_25329375_ChIP-Seq_VCAP_Human | 1.69458211 |
| 26 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.68907624 |
| 27 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.64341893 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58439482 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56597908 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54596304 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.53497262 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53489363 |
| 33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50245902 |
| 34 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.49144811 |
| 35 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47479023 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47479023 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47063610 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.46748688 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45175865 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43417821 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41898163 |
| 42 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.40930035 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39243888 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39021989 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37438238 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.37250793 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37055381 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35816634 |
| 49 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.34629975 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32804671 |
| 51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.32686630 |
| 52 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31877012 |
| 53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30840601 |
| 54 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.29721859 |
| 55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27915557 |
| 56 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.27314251 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.26272613 |
| 58 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.24167834 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22649559 |
| 60 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22432972 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21911284 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21792573 |
| 63 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.21666597 |
| 64 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.20036165 |
| 65 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19343187 |
| 66 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18406186 |
| 67 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18406186 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18403144 |
| 69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17634628 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17016063 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15524819 |
| 72 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.15209164 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14754928 |
| 74 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.12999305 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12913152 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12475365 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12256143 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12227278 |
| 79 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11834372 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11796794 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11073603 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10651178 |
| 83 | TBL1_22424771_ChIP-Seq_293T_Human | 1.10555093 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09952649 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09952649 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09637541 |
| 87 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.09590886 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07680337 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07076855 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06957994 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06783575 |
| 92 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.06288450 |
| 93 | NCOR_22424771_ChIP-Seq_293T_Human | 1.05927759 |
| 94 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.05746806 |
| 95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05674046 |
| 96 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05327127 |
| 97 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04332581 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03810006 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03042862 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03042862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.93787181 |
| 2 | MP0001968_abnormal_touch/_nociception | 3.45882459 |
| 3 | MP0002638_abnormal_pupillary_reflex | 2.70228385 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.52681975 |
| 5 | MP0002736_abnormal_nociception_after | 2.49398315 |
| 6 | MP0002102_abnormal_ear_morphology | 2.42528691 |
| 7 | MP0005646_abnormal_pituitary_gland | 2.41433747 |
| 8 | MP0009745_abnormal_behavioral_response | 2.37696578 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.21913891 |
| 10 | MP0006072_abnormal_retinal_apoptosis | 2.13486578 |
| 11 | MP0003011_delayed_dark_adaptation | 2.13154964 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.10274610 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.07376514 |
| 14 | MP0009046_muscle_twitch | 2.06244822 |
| 15 | MP0003646_muscle_fatigue | 1.98025017 |
| 16 | MP0004043_abnormal_pH_regulation | 1.96628013 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.91797965 |
| 18 | MP0004145_abnormal_muscle_electrophysio | 1.88906049 |
| 19 | MP0002163_abnormal_gland_morphology | 1.79839422 |
| 20 | MP0002272_abnormal_nervous_system | 1.77558486 |
| 21 | MP0005253_abnormal_eye_physiology | 1.77038378 |
| 22 | MP0003787_abnormal_imprinting | 1.76341799 |
| 23 | MP0004142_abnormal_muscle_tone | 1.71237048 |
| 24 | MP0001486_abnormal_startle_reflex | 1.69756281 |
| 25 | MP0008877_abnormal_DNA_methylation | 1.66477208 |
| 26 | MP0003252_abnormal_bile_duct | 1.61977056 |
| 27 | MP0001984_abnormal_olfaction | 1.56418715 |
| 28 | MP0001905_abnormal_dopamine_level | 1.53995050 |
| 29 | MP0002064_seizures | 1.52868719 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.49059784 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.48541507 |
| 32 | MP0005171_absent_coat_pigmentation | 1.47625229 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.40234877 |
| 34 | MP0003195_calcinosis | 1.39754152 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39396647 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.38143123 |
| 37 | MP0005389_reproductive_system_phenotype | 1.37344309 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.35222776 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.33465401 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.33383378 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.33259280 |
| 42 | MP0002160_abnormal_reproductive_system | 1.29026883 |
| 43 | MP0004885_abnormal_endolymph | 1.27718786 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.27511394 |
| 45 | MP0000230_abnormal_systemic_arterial | 1.26709676 |
| 46 | MP0003136_yellow_coat_color | 1.23659988 |
| 47 | MP0001970_abnormal_pain_threshold | 1.22863845 |
| 48 | MP0000749_muscle_degeneration | 1.20711667 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.20079672 |
| 50 | MP0000631_abnormal_neuroendocrine_gland | 1.19822568 |
| 51 | MP0000427_abnormal_hair_cycle | 1.19801659 |
| 52 | MP0003635_abnormal_synaptic_transmissio | 1.19527794 |
| 53 | MP0004130_abnormal_muscle_cell | 1.19346290 |
| 54 | MP0003878_abnormal_ear_physiology | 1.19069489 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.19069489 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.17325535 |
| 57 | MP0002733_abnormal_thermal_nociception | 1.16419949 |
| 58 | MP0005670_abnormal_white_adipose | 1.15968061 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.14455234 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.14416532 |
| 61 | MP0003137_abnormal_impulse_conducting | 1.13465051 |
| 62 | MP0003880_abnormal_central_pattern | 1.12174562 |
| 63 | MP0002067_abnormal_sensory_capabilities | 1.10673031 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.08705204 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.07164631 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.06026492 |
| 67 | MP0004924_abnormal_behavior | 1.06026492 |
| 68 | MP0002234_abnormal_pharynx_morphology | 1.05746537 |
| 69 | MP0004484_altered_response_of | 1.04832274 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.01490512 |
| 71 | MP0006292_abnormal_olfactory_placode | 1.00942416 |
| 72 | MP0001919_abnormal_reproductive_system | 1.00808805 |
| 73 | MP0005310_abnormal_salivary_gland | 0.99221577 |
| 74 | MP0004147_increased_porphyrin_level | 0.98275776 |
| 75 | MP0001440_abnormal_grooming_behavior | 0.97999531 |
| 76 | MP0000026_abnormal_inner_ear | 0.97431249 |
| 77 | MP0000371_diluted_coat_color | 0.95937514 |
| 78 | MP0002063_abnormal_learning/memory/cond | 0.95419033 |
| 79 | MP0004215_abnormal_myocardial_fiber | 0.94715536 |
| 80 | MP0005195_abnormal_posterior_eye | 0.91741431 |
| 81 | MP0002938_white_spotting | 0.90971161 |
| 82 | MP0005410_abnormal_fertilization | 0.90737329 |
| 83 | MP0002752_abnormal_somatic_nervous | 0.88878703 |
| 84 | MP0005647_abnormal_sex_gland | 0.87937877 |
| 85 | MP0005423_abnormal_somatic_nervous | 0.84879091 |
| 86 | MP0005620_abnormal_muscle_contractility | 0.84228989 |
| 87 | MP0003938_abnormal_ear_development | 0.84178305 |
| 88 | MP0000049_abnormal_middle_ear | 0.82709067 |
| 89 | MP0005448_abnormal_energy_balance | 0.82585065 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.82189248 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.81041548 |
| 92 | MP0008872_abnormal_physiological_respon | 0.79564388 |
| 93 | MP0002557_abnormal_social/conspecific_i | 0.76710091 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.75669226 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.75332239 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.74454363 |
| 97 | MP0004133_heterotaxia | 0.71311971 |
| 98 | MP0003879_abnormal_hair_cell | 0.71227864 |
| 99 | MP0000516_abnormal_urinary_system | 0.70667944 |
| 100 | MP0005367_renal/urinary_system_phenotyp | 0.70667944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 3.96123064 |
| 2 | Genetic anticipation (HP:0003743) | 3.81154675 |
| 3 | Progressive cerebellar ataxia (HP:0002073) | 3.77126206 |
| 4 | Pancreatic cysts (HP:0001737) | 3.70505809 |
| 5 | True hermaphroditism (HP:0010459) | 3.57929480 |
| 6 | Absence seizures (HP:0002121) | 3.55527149 |
| 7 | Congenital sensorineural hearing impairment (HP:0008527) | 3.53451363 |
| 8 | Dialeptic seizures (HP:0011146) | 3.48930747 |
| 9 | Pancreatic fibrosis (HP:0100732) | 3.46526215 |
| 10 | Congenital stationary night blindness (HP:0007642) | 3.46136453 |
| 11 | Decreased circulating renin level (HP:0003351) | 3.43249244 |
| 12 | Abnormality of midbrain morphology (HP:0002418) | 3.38585153 |
| 13 | Molar tooth sign on MRI (HP:0002419) | 3.38585153 |
| 14 | Focal seizures (HP:0007359) | 3.27660262 |
| 15 | Type 2 muscle fiber atrophy (HP:0003554) | 3.09611598 |
| 16 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.08163573 |
| 17 | Action tremor (HP:0002345) | 3.06491748 |
| 18 | Abolished electroretinogram (ERG) (HP:0000550) | 3.03817518 |
| 19 | Hyperglycinemia (HP:0002154) | 3.01538879 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 2.89996859 |
| 21 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.80815830 |
| 22 | Absent/shortened dynein arms (HP:0200106) | 2.80815830 |
| 23 | Attenuation of retinal blood vessels (HP:0007843) | 2.80577414 |
| 24 | Increased circulating renin level (HP:0000848) | 2.80367931 |
| 25 | Hyperventilation (HP:0002883) | 2.77410046 |
| 26 | Pendular nystagmus (HP:0012043) | 2.74137828 |
| 27 | Abnormality of renin-angiotensin system (HP:0000847) | 2.73872978 |
| 28 | Abnormal ciliary motility (HP:0012262) | 2.68674415 |
| 29 | Prostate neoplasm (HP:0100787) | 2.67365825 |
| 30 | Nephronophthisis (HP:0000090) | 2.66526365 |
| 31 | Medial flaring of the eyebrow (HP:0010747) | 2.65973393 |
| 32 | Abnormal drinking behavior (HP:0030082) | 2.64461260 |
| 33 | Polydipsia (HP:0001959) | 2.64461260 |
| 34 | Atonic seizures (HP:0010819) | 2.62000402 |
| 35 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.61763401 |
| 36 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.59340131 |
| 37 | Polyuria (HP:0000103) | 2.58763323 |
| 38 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.58699180 |
| 39 | Decreased muscle mass (HP:0003199) | 2.53318079 |
| 40 | Muscle fiber atrophy (HP:0100295) | 2.53000004 |
| 41 | Febrile seizures (HP:0002373) | 2.51148543 |
| 42 | Hyperactive renin-angiotensin system (HP:0000841) | 2.49993504 |
| 43 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.47246863 |
| 44 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.45061719 |
| 45 | Clumsiness (HP:0002312) | 2.43306031 |
| 46 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.42781467 |
| 47 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.42781467 |
| 48 | Tubular atrophy (HP:0000092) | 2.34459091 |
| 49 | Retinitis pigmentosa (HP:0000510) | 2.33387008 |
| 50 | Abnormality of the hepatic vasculature (HP:0006707) | 2.31630271 |
| 51 | Absent speech (HP:0001344) | 2.26225866 |
| 52 | Congenital, generalized hypertrichosis (HP:0004540) | 2.26161762 |
| 53 | Abnormal number of erythroid precursors (HP:0012131) | 2.23541734 |
| 54 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.23087817 |
| 55 | Male pseudohermaphroditism (HP:0000037) | 2.21129243 |
| 56 | Abnormality of the renal cortex (HP:0011035) | 2.20105575 |
| 57 | Acute necrotizing encephalopathy (HP:0006965) | 2.19611365 |
| 58 | Abnormality of the renal medulla (HP:0100957) | 2.18974510 |
| 59 | Acute encephalopathy (HP:0006846) | 2.18198698 |
| 60 | Sclerocornea (HP:0000647) | 2.17375203 |
| 61 | Anencephaly (HP:0002323) | 2.13687292 |
| 62 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.13265866 |
| 63 | Abnormal urine output (HP:0012590) | 2.09099121 |
| 64 | Cystic liver disease (HP:0006706) | 2.09018781 |
| 65 | Hyperaldosteronism (HP:0000859) | 2.08047409 |
| 66 | Global brain atrophy (HP:0002283) | 2.06516739 |
| 67 | Abnormality of macular pigmentation (HP:0008002) | 2.03692195 |
| 68 | Gait imbalance (HP:0002141) | 2.02926652 |
| 69 | Hemiplegia (HP:0002301) | 2.02587605 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.01418854 |
| 71 | Chorioretinal atrophy (HP:0000533) | 2.00489828 |
| 72 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.00053588 |
| 73 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.00021481 |
| 74 | Hypokalemic alkalosis (HP:0001949) | 1.98955086 |
| 75 | Severe visual impairment (HP:0001141) | 1.96881188 |
| 76 | Anomalous pulmonary venous return (HP:0010772) | 1.95482639 |
| 77 | Metabolic alkalosis (HP:0200114) | 1.94531194 |
| 78 | Progressive macrocephaly (HP:0004481) | 1.93442030 |
| 79 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.90027541 |
| 80 | Nephrogenic diabetes insipidus (HP:0009806) | 1.89952649 |
| 81 | Tachypnea (HP:0002789) | 1.88313485 |
| 82 | Left ventricular hypertrophy (HP:0001712) | 1.87969233 |
| 83 | Abnormality of renal excretion (HP:0011036) | 1.87205809 |
| 84 | Syncope (HP:0001279) | 1.86504357 |
| 85 | Abnormality of alanine metabolism (HP:0010916) | 1.86441727 |
| 86 | Hyperalaninemia (HP:0003348) | 1.86441727 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86441727 |
| 88 | Constricted visual fields (HP:0001133) | 1.84493420 |
| 89 | Dysmetric saccades (HP:0000641) | 1.83833179 |
| 90 | Vitreoretinal degeneration (HP:0000655) | 1.83549451 |
| 91 | Postural instability (HP:0002172) | 1.82664673 |
| 92 | Stenosis of the external auditory canal (HP:0000402) | 1.81172682 |
| 93 | Mitochondrial inheritance (HP:0001427) | 1.80410227 |
| 94 | Impaired smooth pursuit (HP:0007772) | 1.80128583 |
| 95 | Mesangial abnormality (HP:0001966) | 1.79931099 |
| 96 | Atrial fibrillation (HP:0005110) | 1.79802400 |
| 97 | Genital tract atresia (HP:0001827) | 1.78771782 |
| 98 | Hypochromic microcytic anemia (HP:0004840) | 1.77578870 |
| 99 | Hyperglycinuria (HP:0003108) | 1.76776481 |
| 100 | Nonprogressive disorder (HP:0003680) | 1.75610407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.35689279 |
| 2 | CDK19 | 4.41471184 |
| 3 | OXSR1 | 3.38625917 |
| 4 | PINK1 | 3.36324096 |
| 5 | MUSK | 2.51586627 |
| 6 | WNK3 | 2.47135982 |
| 7 | ADRBK2 | 2.45731970 |
| 8 | CASK | 2.44556289 |
| 9 | TXK | 2.42282710 |
| 10 | GRK1 | 2.34469472 |
| 11 | TAOK3 | 1.94632088 |
| 12 | BMPR1B | 1.87318613 |
| 13 | STK39 | 1.71694351 |
| 14 | TIE1 | 1.69888316 |
| 15 | INSRR | 1.61081856 |
| 16 | WNK4 | 1.60434423 |
| 17 | BLK | 1.57968426 |
| 18 | MAP4K2 | 1.57579614 |
| 19 | TLK1 | 1.53305063 |
| 20 | ZAK | 1.31958099 |
| 21 | MAP3K7 | 1.31779576 |
| 22 | OBSCN | 1.28738540 |
| 23 | STK3 | 1.22375340 |
| 24 | STK38L | 1.18406955 |
| 25 | NTRK3 | 1.14066369 |
| 26 | ADRBK1 | 1.06761860 |
| 27 | TEC | 1.06550781 |
| 28 | STK16 | 1.06149051 |
| 29 | CAMKK2 | 1.04166405 |
| 30 | NUAK1 | 1.03928365 |
| 31 | ACVR1B | 0.95238161 |
| 32 | MAPK15 | 0.90680715 |
| 33 | STK11 | 0.89788176 |
| 34 | MAPK13 | 0.86611027 |
| 35 | PIK3CA | 0.85532848 |
| 36 | GRK7 | 0.85226894 |
| 37 | PRKD2 | 0.82867463 |
| 38 | FGFR2 | 0.82334162 |
| 39 | TGFBR1 | 0.78492119 |
| 40 | WNK1 | 0.77244733 |
| 41 | PRKCG | 0.76917947 |
| 42 | MAP3K4 | 0.73906631 |
| 43 | ABL2 | 0.73817781 |
| 44 | PIK3CG | 0.71263566 |
| 45 | TNK2 | 0.70079386 |
| 46 | CAMK1 | 0.66786463 |
| 47 | CDK8 | 0.64832361 |
| 48 | MINK1 | 0.63919776 |
| 49 | MAP2K6 | 0.62351523 |
| 50 | STK38 | 0.61095621 |
| 51 | PRKCE | 0.60276139 |
| 52 | PRKACA | 0.60204279 |
| 53 | PRKG1 | 0.60100862 |
| 54 | SGK2 | 0.58458476 |
| 55 | CAMK2A | 0.55492689 |
| 56 | LATS1 | 0.54795724 |
| 57 | DYRK2 | 0.53651252 |
| 58 | PAK3 | 0.53613304 |
| 59 | EPHA4 | 0.53507570 |
| 60 | NEK1 | 0.52845018 |
| 61 | PHKG2 | 0.51191841 |
| 62 | PHKG1 | 0.51191841 |
| 63 | ERBB2 | 0.50717284 |
| 64 | PRKCA | 0.43844404 |
| 65 | IKBKB | 0.43005834 |
| 66 | SGK494 | 0.42326321 |
| 67 | SGK223 | 0.42326321 |
| 68 | NLK | 0.41245224 |
| 69 | FER | 0.39141006 |
| 70 | NTRK2 | 0.39029366 |
| 71 | CCNB1 | 0.38755022 |
| 72 | PRKCQ | 0.38543322 |
| 73 | MAPKAPK3 | 0.38523500 |
| 74 | SGK1 | 0.38421247 |
| 75 | GRK5 | 0.38178184 |
| 76 | MKNK2 | 0.38014249 |
| 77 | IGF1R | 0.36107338 |
| 78 | ITK | 0.36062208 |
| 79 | DYRK1A | 0.34140966 |
| 80 | PRKACB | 0.33408515 |
| 81 | LCK | 0.32976178 |
| 82 | PRKCZ | 0.32458017 |
| 83 | CSNK1A1 | 0.32292375 |
| 84 | SYK | 0.32014622 |
| 85 | RPS6KA5 | 0.31755144 |
| 86 | KIT | 0.31697008 |
| 87 | LYN | 0.31660813 |
| 88 | CAMK2D | 0.31275763 |
| 89 | RPS6KB2 | 0.31072456 |
| 90 | PIM1 | 0.31069434 |
| 91 | MAPKAPK5 | 0.30345715 |
| 92 | GRK6 | 0.29815542 |
| 93 | PTK2B | 0.29536102 |
| 94 | IRAK1 | 0.28125059 |
| 95 | MAPK7 | 0.27804799 |
| 96 | PDPK1 | 0.26981488 |
| 97 | PLK4 | 0.26916719 |
| 98 | PKN1 | 0.26865803 |
| 99 | MARK1 | 0.26847494 |
| 100 | CAMK2G | 0.26526417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.04077999 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.89815192 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.87967171 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.58649527 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58086096 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29432053 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.25881499 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.19590277 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15282647 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.08047647 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04390268 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.98020128 |
| 13 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.75697329 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.74708583 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.68131105 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.64645578 |
| 17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.64275631 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61796345 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.55551765 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.51479587 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.46556059 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.44897469 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.44548351 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39273936 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35894482 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.31181142 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29622373 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28299532 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27967831 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25811732 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20948366 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20580067 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.18348261 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17340496 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16389073 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.12822122 |
| 37 | RNA polymerase_Homo sapiens_hsa03020 | 1.11675789 |
| 38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10959788 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.09418596 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07602232 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06499016 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04662023 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04063970 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03093538 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.02720481 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01875073 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98825967 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98743326 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98305768 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.98014082 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97392421 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.96243272 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94403416 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93612595 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93204605 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89427465 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89150801 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88880367 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88282760 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87939532 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81260454 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.81159637 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.80883271 |
| 64 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79698710 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74895372 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74407090 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74046094 |
| 68 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71933920 |
| 69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70179373 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.68955038 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.65748375 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65263992 |
| 73 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64549682 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63628528 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63525936 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60493990 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55939799 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.55046086 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48623358 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.48240818 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48128199 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47735767 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46114239 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.45352798 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44990179 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44817339 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43794128 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41442392 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41375268 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41257612 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39898335 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38182019 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38003218 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.36496851 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36125158 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35876118 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35493690 |
| 98 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.35200885 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33805779 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33663018 |

